use both this parameter and , birth_date to display the person's date of birth, date of death, and age at death) --> , death_place = , death_cause = , body_discovered = , resting_place = , resting_place_coordinates = , burial_place = , burial_coordinates = , monuments = , alma_mater =

Northwestern University Northwestern University (NU) is a Private university, private research university in Evanston, Illinois, United States. Established in 1851 to serve the historic Northwest Territory, it is the oldest University charter, chartered university in ...

University of Cambridge The University of Cambridge is a Public university, public collegiate university, collegiate research university in Cambridge, England. Founded in 1209, the University of Cambridge is the List of oldest universities in continuous operation, wo ...

University of Reading The University of Reading is a public research university in Reading, Berkshire, England. It was founded in 1892 as the University Extension College, Reading, an extension college of Christchurch College, Oxford, and became University College, ...

, occupation = Law professor , years_active = , era = , employer = Boston University School of Law , organization = , agent = , known_for = Health Law, Intellectual Property Law, Antibiotic Resistance , notable_works = , style = , height = , television = , title = , term = , predecessor = , successor = , party = , movement = , opponents = , boards = , criminal_charges = , criminal_penalty = , criminal_status = , spouse = , partner = , children = , parents = , mother = , father = , relatives = , family = , callsign = , awards = , website = , module = , module2 = , module3 = , module4 = , module5 = , module6 = , signature = , signature_size = , signature_alt = , footnotes = Kevin Outterson is a lawyer, a professor of law and the Austin B. Fletcher Professor

Boston University Boston University (BU) is a Private university, private research university in Boston, Massachusetts, United States. BU was founded in 1839 by a group of Boston Methodism, Methodists with its original campus in Newbury (town), Vermont, Newbur ...

School of Law (2023-present). He is also the executive director of Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator
CARB-X
, a global non-profit partnership that supports companies developing new antibiotics, diagnostics, vaccines and other products to address drug-resistant bacterial infections. CARB-X is funded by the United States, United Kingdom, German, and Canadian governments, Wellcome, the Bill & Melinda Gates Foundation, and the Novo Nordisk Foundation. In 2022, CARB-X received a new commitment of funding from BARDA and Wellcome of up to $370 million. In 2023, the German and UK governments renewed funding to CARB-X, committing an additional €41 million and £24 million; the government of Canada committed CAD$6.3 million over two years; and The Novo Nordisk Foundation committed USD$25 million over three years. The G7 Health Ministers have cited CARB-X among the critical initiatives to support as the G7 governments renew their 2021 commitment to address the most dangerous drug-resistant infections. In May 2023, the global threat of Antimicrobial Resistance and the importance off supporting CARB-X as a global push incentive that coordinates and accelerates much-needed antibacterial innovation was featured in G7 Hiroshima Leaders’ Communiqué and the G7 Nagasaki Health Ministers’ Communiqué. The same year, G20 Health Ministers cited CARB-X as playing a critical role in accelerating antimicrobial R&D and access. In May 2024, the Antimicrobial Resistance (AMR) Multi-Stakeholder Partnership Platform issued a call for actionable steps to address the rising threat of AMR ahead of the United Nations General Assembly High-Level Meeting on AMR in September 2024. The call recommended increasing public investment in push incentives to catalyze global antimicrobial R&D efforts and cited CARB-X as a push mechanism that should be mobilized due to CARB-X’s critical role in supporting the discovery and development or new antimicrobials. Outterson's research focuses primarily on the

law and economics Law and economics, or economic analysis of law, is the application of microeconomic theory to the analysis of law. The field emerged in the United States during the early 1960s, primarily from the work of scholars from the Chicago school of econ ...

antibiotic resistance Antimicrobial resistance (AMR or AR) occurs when microbes evolve mechanisms that protect them from antimicrobials, which are drugs used to treat infections. This resistance affects all classes of microbes, including bacteria (antibiotic resis ...

–including push and pull incentives–

health law Health law is a field of law that encompasses federal, state, and local law, rules, regulations and other jurisprudence among providers, payers and vendors to the health care industry and its patients, and delivery of health care services, with a ...

intellectual property Intellectual property (IP) is a category of property that includes intangible creations of the human intellect. There are many types of intellectual property, and some countries recognize more than others. The best-known types are patents, co ...

, and global access to medicine. Outterson has testified before

Congress A congress is a formal meeting of the representatives of different countries, constituent states, organizations, trade unions, political parties, or other groups. The term originated in Late Middle English to denote an encounter (meeting of ...

, the

World Health Organization The World Health Organization (WHO) is a list of specialized agencies of the United Nations, specialized agency of the United Nations which coordinates responses to international public health issues and emergencies. It is headquartered in Gen ...

(WHO), UK Parliamentary working groups, and for the District of Columbia, Massachusetts, Vermont, California and West Virginia state legislatures. He is co-director of the health law program at Boston University School of Law (2007–present) and associate fellow at the Royal Institute of International Affairs at Chatham House, London (2014–present). He served on the Board of the American Society of Law, Medicine & Ethics, and serves as faculty editor to th''e American Journal of Law & Medicine'' (2007–present). He is past editor-in-chief of the ''Journal of Law, Medicine & Ethics'' (2010–2016).

References

External links

*
Racing the clock to stop drug-resistant superbugs

The Boston Globe ''The Boston Globe,'' also known locally as ''the Globe'', is an American daily newspaper founded and based in Boston, Massachusetts. The newspaper has won a total of 27 Pulitzer Prizes. ''The Boston Globe'' is the oldest and largest daily new ...

by Maryn McKenna
Accelerating global innovation to address antibacterial resistance: introducing CARB-X
Nature Reviews Drug Discovery
Can we prevent antibiotic resistance?The Brink
b
Robin Berghaus

Antibiotic-resistant infections could dwarf the COVID-19 pandemic

by Kevin Outterson an
Henry Skinner

A better way to fund the fight against superbugs

Bloomberg Bloomberg may refer to: People * Daniel J. Bloomberg (1905–1984), audio engineer * Georgina Bloomberg (born 1983), professional equestrian * Michael Bloomberg (born 1942), American businessman and founder of Bloomberg L.P.; politician a ...

b
James Paton

Boston Business Journal b
Rowan Walrath

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X)
Progress, Potential, and Possibilities hosted b
Ira Pastor

The Global Burden of AMR
Infectious Conversations hosted b
Candace DeMatteisPartnership to Fight Infectious Disease

Antibiotic Resistance: How CARB-X Helps New Companies Get a Running Start
The State of Health wit
Gunnar Esiason
Year of birth missing (living people) Living people Boston University faculty American lawyers Northwestern University alumni Medical journal editors {{US-law-bio-stub